Transferase Inhibitors

Cat.No. Product Name Information Product Use Citations Product Validations
E0120 2-Bromohexadecanoic acid (2-BP) 2-BP (2-Bromohexadecanoic acid) is a nonmetabolisable analogue of palmitate and acts as a palmitoylation inhibitor, which inhibits multiple palmitoyl-acyl Transferase (PAT) activity towards MyrGCK(NBD) and FarnCNRas(NBD) with identical IC50s of approx. 4 µM. 2-Bromohexadecanoic acid can directly and irreversibly inhibit the palmitoyltransferase activity of all DHHC (Asp-His-His-Cys) proteins.
Nat Commun, 2025, 16(1):1762
Adv Sci (Weinh), 2025, 12(40):e05702
Cell Death Dis, 2025, 16(1):17
S2674 A-922500 (DGAT-1 Inhibitor 4a) A922500 (DGAT-1 Inhibitor 4a) is an inhibitor for human and mouse DGAT-1 with IC50 of 7 nM and 24 nM, respectively, good selectivity over related acyltransferases, hERG, and a panel of anti-targets.
Cell Death Discov, 2025, 11(1):21
Nature, 2023, 621(7977):171-178
Cell Rep, 2022, 41(11):111827
S9835 OSMI-1 OSMI-1 is a cell-permeable O-GlcNAc Transferase (OGT) inhibitor with IC50 of 2.7 μM for full length human OGT (ncOGT).
Nat Commun, 2025, 16(1):1274
Cell Death Dis, 2024, 15(4):244
Commun Biol, 2024, 7(1):1530
S7192 PF-04620110 PF-04620110 is an orally active, selective and potent diglyceride acyltransferase-1 (DGAT1) inhibitor with IC50 of 19 nM.
Cell Rep, 2025, 44(8):116100
Commun Biol, 2025, 8(1):1169
J Pharm Biomed Anal, 2019, 170:176-186
S9231 Schisanhenol Schisanhenol (Gomisin K3) is a compound derived from the fruit of a traditional Chinese herb Schisandra rubriflora, exhibiting strong inhibition toward UGT2B7.
Exploratory Research and Hypothesis in Medicine, 2023, 10.14218/ERHM.2023.00054
S3945 L-Cycloserine L-Cycloserine (Levcycloserine, Levcicloserina, Levcycloserinum, (-)-Cycloserine, (S)-Cycloserine) is a potent inhibitor of the sphingolipid pathway via inhibiting 3-ketodihydrosphingosine synthetase. It also inhibits HIV-1 cytopathic effects, replication, and infectivity.
Cancers (Basel), 2024, 16(23)3973
E0081 FIDAS-3 FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for methionine sadenosyltransferase 2A (MAT2A) binding. This compound has anticancer activities by inhibiting the expression of oncogenes. It is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for MAT2A.
Cell Death Dis, 2023, 14(8):525
E1017 ERG240 ERG240, a selective inhibitor of branched-chain aminotransferase 1 (BCAT1) with an IC50 of 0.1-1nM, leads to decreased oxygen consumption and glycolysis through the down regulation of IRG1 expression, which leads to decrease itaconate production in human macrophages.
Adv Sci (Weinh), 2023, 10(13):e2206439
S9954 SGN-2FF

SGN-2FF (2-fluorofucose) is an orally bioavailable small-molecule inhibitor of fucosyltransferase that demonstrated encouraging preclinical antitumor activity in mouse models.

Aging Dis, 2023, 14(5):1927-1944
S6392 SHIN1(RZ-2994) SHIN1 (RZ-2994) is an inhibitor of SHMT1/2 (human serine hydroxymethyltransferase 1 and 2) with respective IC50 values of 5 and 13 nM in in vitro assays. It hinders cell growth by gradually reducing purine levels.
Cancers (Basel), 2024, 16(21)3576
S2994 DL-Homocysteine

DL-Homocysteine is a weak neurotoxin that affects the production of kynurenic acid (KYNA) in the brain. This compound inhibits the activity of both KYNA biosynthetic enzymes, kynurenine aminotransferases (KATs) I and II.

S0970 Curzerene Curzerene, a sesquiterpene isolated from the rhizome of Curculigo orchioides Gaertn with anti-cancer activity, inhibits glutathione S-transferase A1 (GSTA1) mRNA and protein expression and induces cell apoptosis.
S5336 Hecogenin Hecogenin (Hocogenin), a steroid saponin isolated from Agave sisalana, is a potent and highly selective inhibitor of UGT1A4 with an IC50 value of 1.5 μM.
E0405 L002 (NSC764414) L002 (NSC764414) is a potent, cell permeable, reversible and specific acetyltransferase p300 (KAT3B) inhibitor with an IC50 of 1.98 μM.
S5449 3-Methoxybenzamide 3-Methoxybenzamide (3-MBA) is a competitive inhibitor of poly(ADP-ribose) synthetase with Ki values of less than 2 μM and also inhibits ADP-ribosyltransferase (ADPRT)
E4639 FIDAS-5 FIDAS-5 is a potent and orally active inhibitor of methionine S-adenosyltransferase 2A (MAT2A) with an IC50 value of 2.1 μM, respectively. This compound effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. It also demonstrates anticancer activity.
S4189 Cyclandelate Cyclandelate (BS 572,3,5,5-Trimethylcyclohexyl mandelate) is an effective inhibitor of rat hepatic acycloenzyme A: cholesterol Acyltransferase (ACAT) with IC50 of 80 μM.
S5166 Benzoyleneurea Benzoyleneurea (2,4-Dihydroxyquinazoline, Quinazolinedione, Quinazoline-2,4-diol) scaffold is used in the synthesis of novel protein geranylgeranyltransferase-I inhibitors. This compound possesses anti-Bacterial activity.
E6008 Miglustat hydrochloride Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) is an effective, reversible, and non-toxic iminosugar and an inhibitor of ceramide-specific glucosyl transferase and β-glucosidase 2, with an IC50 of 32 μM and 81 μM, respectively. It is used in the treatment and research of dyslipidosis-related disorders, including GM1 gangliosidosis, Gaucher type I, Tay-Sachs disease, and Niemann-Pick type C disease (NPCD).
S4280 Meclofenoxate (Centrophenoxine) HCl Meclofenoxate (Centrophenoxine) HCl is an anti-aging drug used to treat the symptoms of senile dementia and Alzheimer's disease, and also inhibits the activity of cholinephosphotransferase.
S1453 Tipifarnib (IND 58359) Tipifarnib is a potent and specific farnesyltransferase (FTase) inhibitor with IC50 of 0.6 nM, its anti-proliferative effects are most prominent in H-ras or N-ras mutant cells. Phase 3.
Sci Rep, 2025, 15(1):6832
PLoS One, 2025, 20(9):e0331440
Cell Rep, 2023, 42(9):113098
Verified customer review of Tipifarnib (IND 58359)
S2797 Lonafarnib (SCH66336) Lonafarnib (SCH66336) is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM in cell-free assays, respectively. Phase 3.
PLoS Pathog, 2025, 21(10):e1013558
iScience, 2025, 28(2):111864
Sci Rep, 2025, 15(1):34331
Verified customer review of Lonafarnib (SCH66336)
S3021 Rimonabant (SR141716) Rimonabant (SR141716) is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane, and it is also a dual inhibitor of acyl CoA:cholesterol acyltransferases(ACAT) 1 and 2 that inhibits mycobacterial MmpL3.
Biol Pharm Bull, 2025, 48(6):769-781
Toxicol Lett, 2023, 374:48-56
Int J Biol Sci, 2022, 18(4):1401-1414
S9849 EIPA (L593754) EIPA (L593754; MH 12-43) acts as an inhibitor of macropinocytosis and sodium-hydrogen exchangers(NHE) (IC50=0.033μg/mL). EIPA blocks the activity of Na(+)/H(+) exchanger, which are plasma membrane proteins implicated in all forms of macropinocytosis.
J Adv Res, 2025, S2090-1232(25)00267-X
J Nanobiotechnology, 2025, 23(1):173
iScience, 2025, 28(2):111830
S4589 Amodiaquine dihydrochloride dihydrate Amodiaquine is a potent, non-competitive inhibitor of histamine N-methyl transferase with estimated Ki of 18.6 nM. It is also used as an antimalarial and anti-inflammatory agent.
Cell Death Differ, 2023, 10.1038/s41418-023-01167-4
Nat Biomed Eng, 2021, 10.1038/s41551-021-00718-9
J Med Chem, 2020, 31
S4743 Wogonin Wogonin (Vogonin), a natural and biologically-active flavonoid found in plants, is an inhibitor of CDK9 and does not inhibit CDK2, CDK4 and CDK6 at doses that inhibit CDK9 activity; This compound also inhibits N-acetyltransferase.
Cell Rep Med, 2025, S2666-3791(25)00231-9
Cancers -Basel, 2022, 14-174200
J Surg Res, 2021, 263:236-244
Verified customer review of Wogonin
S4021 Tolcapone Tolcapone (Ro 40-7592) is a selective, potent and reversible catechol-O-methyl transferase (COMT) inhibitor with Ki of 30 nM.
FASEB J, 2022, 36(7):e22399
Viruses, 2021, 13(8)1533
Front Bioinform, 2021, 1:710591
S0359 T863 (DGAT-3) T863 (DGAT-3) is a potent, selective and orally active inhibitor of Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) that acts on the acyl-CoA binding site of DGAT1 and inhibits DGAT1-mediated triacylglycerol formation in cells.
J Virol, 2024, 98(11):e0110324
J Cell Sci, 2024, 137(20)jcs262162
S7467 LB42708 LB42708 is an orally active farnesyltransferase (FTase) inhibitor with IC50 of 0.8, 1.2, and 2.0 nM toward H-ras, N-ras, and K-ras, respectively.
Cancer Res Commun, 2024, 10.1158/2767-9764.CRC-24-0221
E1029 Miglustat (N-Butyldeoxynojirimycin)

Miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) is an orally administered ceramide glucosyltransferase inhibitor which prevents the lysosomal accumulation of glucocerebroside.

E1944 Rentosertib (INS018-055, ISM001-055) INS018-055 (ISM001-055, TNIK&MAP4K4-IN-2, compound 112) is an inhibitor of TNIK and MAP4K4. It exhibits IC50 values of 12-120 nM on TNIK.
S6886 1-Aminobenzotriazole 1-Aminobenzotriazole (ABT, 3-Aminobenzotriazole, 1-Benzotriazolylamine, NSC 114498, NSC 656987) is a nonselective and irreversible inhibitor of cytochrome P450 (CYP) enzymes. This compound is also a substrate and inhibitor of N-acetyltransferase (NAT).